Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://primetherapeutics.com/w/prime-therapeutics-supports-fda-s-updated-biosimilar-recommendations Example Link

Press Releases, Specialty drugs

Prime Therapeutics supports FDA’s updated biosimilar recommendations

October 30, 2025

https://primetherapeutics.com/w/five-research-posters-presented-at-amcp-nexus-2025 /amcp-nexus-2025-research-posters

Research & Publications

Five research posters presented at AMCP Nexus 2025

October 30, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-radiopharmaceuticals-revolutionize-cancer-care

Stories

AMCP Nexus 2025: Radiopharmaceuticals revolutionize cancer care

October 30, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-a-deep-dive-into-prostate-cancer-treatment

Stories

AMCP Nexus 2025: A deep dive into prostate cancer treatment

October 30, 2025

The Latest

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-therapeutics-supports-fda-s-updated-biosimilar-recommendations

Prime Therapeutics supports FDA’s updated biosimilar recommendations

October 30, 2025

https://primetherapeutics.com/w/prime-therapeutics-to-present-latest-managed-care-pharmacy-insights-at-amcp-nexus-2025

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

October 27, 2025

https://primetherapeutics.com/w/prime-therapeutics-engages-pwc-to-support-judi-platform-implementations

Prime Therapeutics Engages PwC to Support Judi® Platform Implementations

October 01, 2025

https://primetherapeutics.com/w/what-s-driving-medical-benefit-spend-prime-therapeutics-trend-report-shares-new-clues

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

September 04, 2025

https://primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

June 25, 2025

https://primetherapeutics.com/w/prime-therapeutics-highlights-industry-leading-glp-1-research-at-amcp-2025

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

March 31, 2025

Showing 1 to 6 of 40

Categories

PA Sub-Categories

https://primetherapeutics.com/w/integrated-oncology-insights-navigating-the-medical-and-pharmacy-claims-landscape

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

October 23, 2025

https://primetherapeutics.com/w/how-to-safely-dispose-of-medications-on-national-drug-take-back-day

How to safely dispose of medications on National Drug Take Back Day

October 20, 2025

https://primetherapeutics.com/w/15-years-of-insight-prime-s-medical-pharmacy-trend-report-a-must-read-for-payers

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

October 02, 2025

https://primetherapeutics.com/w/abby-kim-leads-the-charge-in-advancing-lung-cancer-care

Abby Kim leads the charge in advancing lung cancer care

October 01, 2025

https://primetherapeutics.com/w/making-sense-of-most-favored-nation-and-other-proposed-health-care-policies

Making sense of most favored nation and other proposed health care policies

September 30, 2025

https://primetherapeutics.com/w/prime-s-biosimilar-strategy-drives-optionality-for-health-plans

Prime’s biosimilar strategy drives optionality for health plans

August 07, 2025

Showing 1 to 6 of 66

Categories

PA Sub-Categories

https://primetherapeutics.com/w/amcp-nexus-2025-radiopharmaceuticals-revolutionize-cancer-care

AMCP Nexus 2025: Radiopharmaceuticals revolutionize cancer care

October 30, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-a-deep-dive-into-prostate-cancer-treatment

AMCP Nexus 2025: A deep dive into prostate cancer treatment

October 30, 2025

https://primetherapeutics.com/w/recap-academy-of-managed-care-pharmacy-amcp-nexus-2025

RECAP: Academy of Managed Care Pharmacy (AMCP) Nexus 2025

October 30, 2025

https://primetherapeutics.com/w/treatment-breakthroughs-and-managed-care-innovations-highlighted-at-amcp-nexus-2025

Treatment breakthroughs and managed care innovations highlighted at AMCP Nexus 2025

October 29, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-prime-s-glp-1-persistence-research-recognized-with-platinum-award

AMCP Nexus 2025: Prime’s GLP-1 persistence research recognized with platinum award

October 29, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-what-s-new-in-retinal-therapies-prime-experts-share-anti-vegf-advancements

AMCP Nexus 2025: What’s new in retinal therapies? Prime experts share anti-VEGF advancements

October 29, 2025

Showing 1 to 6 of 155

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-presents-at-73rd-annual-roy-a-bowers-pharmaceutical-conference-on-nov-11

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

October 29, 2025

https://primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://primetherapeutics.com/w/prime-presents-2025-medical-pharmacy-trend-report-webcast-on-oct-13

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

September 23, 2025

https://primetherapeutics.com/w/prime-expert-presents-at-the-most-favored-nation-mandate-webinar

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

September 02, 2025

https://primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

Showing 1 to 6 of 37

Categories

PA Sub-Categories

https://primetherapeutics.com/w/fierce-healthcare-prime-therapeutics-takes-sempre-health-s-pricing-model-nationwide https://www.fiercehealthcare.com/payers/prime-therapeutics-takes-sempre-healths-pricing-model-nationwide

Fierce Healthcare: Prime Therapeutics takes Sempre Health's pricing model nationwide

October 30, 2025

https://primetherapeutics.com/w/fierce-healthcare-emblemhealth-taps-prime-therapeutics-amazon-for-new-pharmacy-benefit-collaboration https://www.fiercehealthcare.com/payers/emblemhealth-taps-prime-therapeutics-amazon-new-pharmacy-benefit-collaboration

Fierce Healthcare: EmblemHealth taps Prime Therapeutics, Amazon for new pharmacy benefit collaboration

October 29, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-real-world-study-shows-330-000-cost-difference-between-car-t-and-bite-therapies-amcp-nexus-2025 https://www.managedhealthcareexecutive.com/view/real-world-study-shows-330-000-cost-difference-between-car-t-and-bite-therapies-amcp-nexus-2025

Managed Healthcare Executive: Real-World Study Shows $330,000 Cost Difference Between CAR T and BiTE Therapies | AMCP Nexus 2025

October 29, 2025

https://primetherapeutics.com/w/specialty-pharmacy-continuum-addressing-inequities-in-food-allergy-prevention-and-treatment https://www.specialtypharmacycontinuum.com/Clinical/Article/10-25/Addressing-Inequities-in-Food-Allergy-Prevention-and-Treatment/78403

Specialty Pharmacy Continuum: Addressing Inequities in Food Allergy Prevention and Treatment

October 06, 2025

https://primetherapeutics.com/w/payer-perspectives-prime-provides-integrated-medical-pharmacy-claims-data-for-certain-classes https://payerperspectives.substack.com/p/prime-provides-integrated-medical

Payer Perspectives: Prime Provides Integrated Medical, Pharmacy Claims Data for Certain Classes

October 02, 2025

https://primetherapeutics.com/w/fda-drops-rems-for-car-t-rx-will-access-expand- https://www.pharmacypracticenews.com/Clinical/Oncology/Article/09-25/FDA-Removes-CAR-T-REMS/78266

Pharmacy Practice News: FDA Drops REMS for CAR-T Rx; Will Access Expand?

September 25, 2025

Showing 1 to 6 of 122

Categories

PA Research & Publications

https://primetherapeutics.com/w/five-research-posters-presented-at-amcp-nexus-2025 /amcp-nexus-2025-research-posters

Five research posters presented at AMCP Nexus 2025

October 30, 2025

https://primetherapeutics.com/w/quarterly-drug-approvals-october-2025 /quarterly-drug-approvals-october-2025

Quarterly Drug Approvals: October 2025

October 30, 2025

https://primetherapeutics.com/w/quarterly-drug-pipeline-october-2025 /quarterly-drug-pipeline-october-2025

Quarterly Drug Pipeline: October 2025

October 30, 2025

https://primetherapeutics.com/w/oncology-insights-october-2025 /oncology-insights-october-2025

Oncology Insights: October 2025

October 21, 2025

https://primetherapeutics.com/w/high-cost-therapy-profile-october-2025 /high-cost-therapy-profile-october-2025

High-Cost Therapy Profile: October 2025

October 15, 2025

https://primetherapeutics.com/w/fda-decisions-expected-november-2025 /fda-decisions-expected-november-2025

FDA Decisions Expected: November 2025

October 13, 2025

Showing 1 to 6 of 180

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

Read &#8211; News, Research &amp; Insights from Prime Therapeutics - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

Prime Therapeutics supports FDA’s updated biosimilar recommendations

Five research posters presented at AMCP Nexus 2025

AMCP Nexus 2025: Radiopharmaceuticals revolutionize cancer care

AMCP Nexus 2025: A deep dive into prostate cancer treatment

The Latest

Prime Therapeutics supports FDA’s updated biosimilar recommendations

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

Prime Therapeutics Engages PwC to Support Judi® Platform Implementations

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

How to safely dispose of medications on National Drug Take Back Day

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

Abby Kim leads the charge in advancing lung cancer care

Making sense of most favored nation and other proposed health care policies

Prime’s biosimilar strategy drives optionality for health plans

AMCP Nexus 2025: Radiopharmaceuticals revolutionize cancer care

AMCP Nexus 2025: A deep dive into prostate cancer treatment

RECAP: Academy of Managed Care Pharmacy (AMCP) Nexus 2025

Treatment breakthroughs and managed care innovations highlighted at AMCP Nexus 2025

AMCP Nexus 2025: Prime’s GLP-1 persistence research recognized with platinum award

AMCP Nexus 2025: What’s new in retinal therapies? Prime experts share anti-VEGF advancements

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

Prime presents at HLTH USA conference on Oct. 20

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Fierce Healthcare: Prime Therapeutics takes Sempre Health's pricing model nationwide

Fierce Healthcare: EmblemHealth taps Prime Therapeutics, Amazon for new pharmacy benefit collaboration

Managed Healthcare Executive: Real-World Study Shows $330,000 Cost Difference Between CAR T and BiTE Therapies | AMCP Nexus 2025

Specialty Pharmacy Continuum: Addressing Inequities in Food Allergy Prevention and Treatment

Payer Perspectives: Prime Provides Integrated Medical, Pharmacy Claims Data for Certain Classes

Pharmacy Practice News: FDA Drops REMS for CAR-T Rx; Will Access Expand?

Five research posters presented at AMCP Nexus 2025

Quarterly Drug Approvals: October 2025

Quarterly Drug Pipeline: October 2025

Oncology Insights: October 2025

High-Cost Therapy Profile: October 2025

FDA Decisions Expected: November 2025

Login Portals

Compliance / Legal

Company

Read – News, Research & Insights from Prime Therapeutics - Prime Therapeutics